WHEN
Thursday, November 3, 2022
At 5:30 in the evening
[cocktail attire]
M2G Ventures requests the honor of your presence at
Thursday, November 3, 2022
At 5:30 in the evening
[cocktail attire]
The Ostreum
108 South Freeway
Fort Worth, TX 76104
Dinner provided by Chef Marcus Paslay
Cocktails provided by Blackland Distillery
Wine provided by Effectus Group
Venue provided by The Ostreum
Art Curation by Katie Murray
Printing provided by Broadnax 21C Printers & AlphaGraphics
Art of the Mind
Hannah Stephens
hstephens@m2gventures.com
972.935.3210
Learn more about M2G Ventures in Mental Health
Simmons Bank
MWG Enterprises
Empire Holdings
Kelly Hart & Hallman LLP
Pennybacker Capital
Terry & Allison Montesi Foundation
The Miles Foundation Community Fund at the North Texas Community Foundation
Troy & Julie Moncrief
Fidelity Brokerage Services LLC
NAI Robert Lynn
Paslay Group
R & S Miller Family LP
Stockyards Heritage Development Co.
Stream Realty Partners
United Way of Tarrant County
Calvetti Ferguson
JPMorgan Chase & Co.
Kris Miller, Ryann LLC
Qurumbli Foundation
Tom & Ellen Harris
Tommy Pigg
Abrazo Acquisition Group LLC
Chris & Alexa Harden
Kyle & Allyson Valley
Link Partners LLC
Steve Brauer, Jr.
Tanya A. Zielinski, M.D., P.A.
Trivium Capital LLC
Zenith Roofing & Waterproofing
Together, we will change the way we treat mental illness.
To raise $1 million to fund and launch the Center for Depression Research and Clinical Care (CDRC) in our hometown of Fort Worth. At the CDRC, the vision is a future free from the burden of depression. M2G’s partnership with the CDRC aims to bring its services, studies, and resources to children and young adults across our region. The work Dr. Trivedi and his team of researchers are doing is changing the way mental illness is diagnosed and treated, now and in the future.
With your help, we are over halfway to reaching our $1 million, 3-year fundraising goal. Since the opening of the CDRC clinical site at the Moncrief Cancer Institute in 2019, Dr. Trivedi has implemented the Texas Resilience Against Depression (T-RAD) study, which aims to identify biomarkers of depression and resilience. To date, the CDRC site in Fort Worth has enrolled 90 participants. Through innovative programs such as T-RAD, the CDRC is developing practical tests that will transform clinical care for the diagnosis, treatment, and prevention of mood disorders, which will have long-lasting and transformative benefits in our region.
With less than $500,000 to raise by 2023, we remain more committed than ever to our pledge to the CDRC. And with the impact already seen in our community through Dr. Trivedi’s research and programs, we are more inspired than ever. As most grand endeavors go, it takes a village. And we are so grateful to have a circle of supporters who demand better outcomes, earlier intervention, and a path to healing for this and future generations.